top of page

Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19

Published date

December 27, 2022


In patients with severe #COVID19, increased levels of autoantibodies against PAR1 were found. These might serve as allosteric agonists of PAR1 on endothelial cells and platelets, and thus might contribute to the pathogenesis of microthrombosis in COVID-19.

Contribute to the GPCR News

Coming soon

More from Dr. GPCR